133 related articles for article (PubMed ID: 38296630)
1. Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults.
Furian M; Mademilov M; Buergin A; Scheiwiller PM; Mayer L; Schneider S; Emilov B; Lichtblau M; Bitos K; Muralt L; Groth A; Reiser AE; Sevik A; Sheraliev U; Marazhapov NH; Aydaralieva S; Muratbekova A; Tabyshova A; Abdraeva A; Buenzli S; Sooronbaev TM; Ulrich S; Bloch KE
NEJM Evid; 2022 Jan; 1(1):EVIDoa2100006. PubMed ID: 38296630
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Dexamethasone in Preventing Acute Mountain Sickness in COPD Patients: Randomized Trial.
Furian M; Lichtblau M; Aeschbacher SS; Estebesova B; Emilov B; Sheraliev U; Marazhapov NH; Mademilov M; Osmonov B; Bisang M; Ulrich S; Latshang TD; Ulrich S; Sooronbaev TM; Bloch KE
Chest; 2018 Oct; 154(4):788-797. PubMed ID: 29909285
[TBL] [Abstract][Full Text] [Related]
3. Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical Trial.
Tan L; Latshang TD; Aeschbacher SS; Huber F; Flueck D; Lichtblau M; Ulrich S; Hasler ED; Scheiwiller PM; Ulrich S; Bloch KE; Furian M
JAMA Netw Open; 2020 Jun; 3(6):e207940. PubMed ID: 32568400
[TBL] [Abstract][Full Text] [Related]
4. Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.
Nieto Estrada VH; Molano Franco D; Medina RD; Gonzalez Garay AG; Martí-Carvajal AJ; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009761. PubMed ID: 28653390
[TBL] [Abstract][Full Text] [Related]
5. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
Berger MM; Sareban M; Schiefer LM; Swenson KE; Treff F; Schäfer L; Schmidt P; Schimke MM; Paar M; Niebauer J; Cogo A; Kriemler S; Schwery S; Pickerodt PA; Mayer B; Bärtsch P; Swenson ER
J Appl Physiol (1985); 2022 Jun; 132(6):1361-1369. PubMed ID: 35511718
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
Basnyat B; Gertsch JH; Johnson EW; Castro-Marin F; Inoue Y; Yeh C
High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711
[TBL] [Abstract][Full Text] [Related]
7. Effect of Dexamethasone on Nocturnal Oxygenation in Lowlanders With Chronic Obstructive Pulmonary Disease Traveling to 3100 Meters: A Randomized Clinical Trial.
Furian M; Lichtblau M; Aeschbacher SS; Estebesova B; Emilov B; Sheraliev U; Marazhapov NH; Mademilov M; Osmonov B; Bisang M; Ulrich S; Latshang TD; Ulrich S; Sooronbaev TM; Bloch KE
JAMA Netw Open; 2019 Feb; 2(2):e190067. PubMed ID: 30794302
[TBL] [Abstract][Full Text] [Related]
8. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
[TBL] [Abstract][Full Text] [Related]
9. Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.
Molano Franco D; Nieto Estrada VH; Gonzalez Garay AG; Martí-Carvajal AJ; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD013315. PubMed ID: 31012483
[TBL] [Abstract][Full Text] [Related]
10. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
Lipman GS; Jurkiewicz C; Winstead-Derlega C; Navlyt A; Burns P; Walker A; Phillips C; Reilly A; Burnier A; Romero J; Warner K; Hackett P
High Alt Med Biol; 2019 Sep; 20(3):271-278. PubMed ID: 31259608
[No Abstract] [Full Text] [Related]
11. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.
Kayser B; Hulsebosch R; Bosch F
High Alt Med Biol; 2008; 9(1):15-23. PubMed ID: 18331216
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
[TBL] [Abstract][Full Text] [Related]
13. Exercise limitation of acetazolamide at altitude (3459 m).
Bradwell AR; Myers SD; Beazley M; Ashdown K; Harris NG; Bradwell SB; Goodhart J; Imray CH; Wimalasena Y; Edsell ME; Pattinson KT; Wright AD; Harris SJ;
Wilderness Environ Med; 2014 Sep; 25(3):272-7. PubMed ID: 24931587
[TBL] [Abstract][Full Text] [Related]
14. Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs.
Gonzalez Garay A; Molano Franco D; Nieto Estrada VH; Martí-Carvajal AJ; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012983. PubMed ID: 29529715
[TBL] [Abstract][Full Text] [Related]
15. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
Basnyat B; Gertsch JH; Holck PS; Johnson EW; Luks AM; Donham BP; Fleischman RJ; Gowder DW; Hawksworth JS; Jensen BT; Kleiman RJ; Loveridge AH; Lundeen EB; Newman SL; Noboa JA; Miegs DP; O'Beirne KA; Philpot KB; Schultz MN; Valente MC; Wiebers MR; Swenson ER
High Alt Med Biol; 2006; 7(1):17-27. PubMed ID: 16544963
[TBL] [Abstract][Full Text] [Related]
16. Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis.
Ritchie ND; Baggott AV; Andrew Todd WT
J Travel Med; 2012; 19(5):298-307. PubMed ID: 22943270
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention.
Lipman GS; Jurkiewicz C; Burnier A; Marvel J; Phillips C; Lowry C; Hawkins J; Navlyt A; Swenson ER
Am J Med; 2020 Dec; 133(12):e706-e715. PubMed ID: 32479750
[TBL] [Abstract][Full Text] [Related]
18. Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial.
Hillenbrand P; Pahari AK; Soon Y; Subedi D; Bajracharya R; Gurung P; Lal BK; Marahatta R; Pradhan S; Rai D; Sharma S;
Wilderness Environ Med; 2006; 17(2):87-93. PubMed ID: 16805144
[TBL] [Abstract][Full Text] [Related]
19. Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis.
Kayser B; Dumont L; Lysakowski C; Combescure C; Haller G; Tramèr MR
High Alt Med Biol; 2012 Jun; 13(2):82-92. PubMed ID: 22724610
[TBL] [Abstract][Full Text] [Related]
20. Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial).
McIntosh SE; Hemphill M; McDevitt MC; Gurung TY; Ghale M; Knott JR; Thapa GB; Basnyat B; Dow J; Weber DC; K Grissom C
Wilderness Environ Med; 2019 Mar; 30(1):12-21. PubMed ID: 30630671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
